Quarterly report · Q3
2927.TEDINET S100U0BT
Period2023-09-01 → 2024-05-31
Filed2024-07-16
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.3bn | 2023-09-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥25.6bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.7bn | 2022-09-01 → 2023-05-31 | Cons. | Net sales |
| Operating income | ¥1.5bn | 2023-09-01 → 2024-05-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2022-09-01 → 2023-05-31 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2023-09-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.7bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2022-09-01 → 2023-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.5bn | 2023-09-01 → 2024-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥988m | 2022-09-01 → 2023-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥923m | 2023-09-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥682m | 2022-09-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥923m | 2023-09-01 → 2024-05-31 | Cons. | Profit loss |
| Net income | ¥685m | 2022-09-01 → 2023-05-31 | Cons. | Profit loss |
| Total assets | ¥45.8bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥41.1bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥39.9bn | at 2023-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.1bn | at 2024-05-31 | Cons. | Liabilities |
| Total liabilities | ¥27.9bn | at 2023-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.7bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.2bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.8bn | at 2023-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.5bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.2bn | at 2023-08-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥65.78 | 2023-09-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20 | 2024-03-01 → 2024-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.51 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.51 | 2022-09-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.04 | 2023-03-01 → 2023-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥65.71 | 2023-09-01 → 2024-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.46 | 2022-09-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥48.5 | 2022-09-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 29.8% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.9% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.9% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-09-01 → 2024-05-31 | ¥1.8bn |
| Otherother segments | revenue external | 2023-09-01 → 2024-05-31 | ¥1.8bn |
| Otherother segments | revenue intersegment | 2023-09-01 → 2024-05-31 | ¥29m |
| Otherother segments | segment profit | 2023-09-01 → 2024-05-31 | −¥264m |
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-05-31 | −¥107m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-05-31 | −¥107m |
| Reconciling Itemsreconciling | segment profit | 2023-09-01 → 2024-05-31 | −¥473m |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | revenue | 2023-09-01 → 2024-05-31 | ¥3.9bn |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | revenue external | 2023-09-01 → 2024-05-31 | ¥3.9bn |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | revenue intersegment | 2023-09-01 → 2024-05-31 | ¥3m |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | segment profit | 2023-09-01 → 2024-05-31 | ¥26m |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | revenue | 2023-09-01 → 2024-05-31 | ¥1.6bn |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | revenue external | 2023-09-01 → 2024-05-31 | ¥1.6bn |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | revenue intersegment | 2023-09-01 → 2024-05-31 | ¥6m |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | segment profit | 2023-09-01 → 2024-05-31 | −¥22m |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue | 2023-09-01 → 2024-05-31 | ¥13.4bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue external | 2023-09-01 → 2024-05-31 | ¥13.4bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue intersegment | 2023-09-01 → 2024-05-31 | ¥69m |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | segment profit | 2023-09-01 → 2024-05-31 | ¥2.1bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue | 2023-09-01 → 2024-05-31 | ¥1.7bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue external | 2023-09-01 → 2024-05-31 | ¥1.7bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | segment profit | 2023-09-01 → 2024-05-31 | ¥132m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-09-01 → 2024-05-31 | ¥22.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-09-01 → 2024-05-31 | ¥22.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-09-01 → 2024-05-31 | ¥107m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-09-01 → 2024-05-31 | ¥2.0bn |
| Otherother segments | revenue | 2022-09-01 → 2023-05-31 | ¥965m |
| Otherother segments | revenue external | 2022-09-01 → 2023-05-31 | ¥965m |
| Otherother segments | segment profit | 2022-09-01 → 2023-05-31 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-09-01 → 2023-05-31 | −¥393m |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | revenue | 2022-09-01 → 2023-05-31 | ¥4.0bn |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | revenue external | 2022-09-01 → 2023-05-31 | ¥4.0bn |
| jpcrp040300-q3r_E01064-000Department Store Businessreportable segment | segment profit | 2022-09-01 → 2023-05-31 | ¥11m |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | revenue | 2022-09-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | revenue external | 2022-09-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q3r_E01064-000Food Service Businessreportable segment | segment profit | 2022-09-01 → 2023-05-31 | −¥114m |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue | 2022-09-01 → 2023-05-31 | ¥11.1bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | revenue external | 2022-09-01 → 2023-05-31 | ¥11.1bn |
| jpcrp040300-q3r_E01064-000Health Carereportable segment | segment profit | 2022-09-01 → 2023-05-31 | ¥1.4bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue | 2022-09-01 → 2023-05-31 | ¥1.6bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | revenue external | 2022-09-01 → 2023-05-31 | ¥1.6bn |
| jpcrp040300-q3r_E01064-000Medical Productsreportable segment | segment profit | 2022-09-01 → 2023-05-31 | ¥152m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-05-31 | ¥18.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-05-31 | ¥18.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-05-31 | ¥1.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 394
| Item | Context | Value | Unit |
|---|---|---|---|
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社ＡＦＣ－ＨＤアムスライフサイエンス | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)静岡県静岡市駿河区豊田三丁目６番36号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding trade notes receivable discounted or transferred by endorsement (text) | CurrentQuarterInstant | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |